Inventor · disambiguated record
Jeno Gyuris
Also filed as: GYURIS JENO · GYURIS JENOE
41 granted patents·25 pending applications·522 citations·filing 1994–2025
98Inventor score
Top patents by PatentIndex Score
66 records- 0195US7649083B2Hepatocyte growth factor (HGF) binding antibodyAVEO PHARMACEUTICALS INC·Filed 2007·Granted Jan 19, 2010·29 cites·9 claims
- 0293US8187601B2Fibroblast growth factor receptor 3 (FGFR3) binding proteinsWENG ZHIGANG·Filed 2009·Granted May 29, 2012·39 cites·11 claims
- 0393US7659378B2Hepatocyte growth factor (HGF) binding antibodyAVEO PHARMACEUTICALS INC·Filed 2007·Granted Feb 9, 2010·17 cites·7 claims
- 0492US9175076B2Anti-GDF15 antibodiesAVEO PHARMACEUTICALS INC·Filed 2013·Granted Nov 3, 2015·16 cites·11 claims
- 0591US11725047B2Anti-GDF-15 antibodiesAVEO PHARMACEUTICALS INC·Filed 2020·Granted Aug 15, 2023·2 cites·20 claims
- 0691US9879083B2Anti-Notch3 antibodiesAVEO PHARMACEUTICALS INC·Filed 2013·Granted Jan 30, 2018·12 cites·23 claims
- 0791US9725505B2Methods of treatment using anti-GDF15 antibodiesAVEO PHARMACEUTICALS INC·Filed 2015·Granted Aug 8, 2017·9 cites·36 claims
- 0891US5580736AInteraction trap system for isolating novel proteinsGEN HOSPITAL CORP·Filed 1995·Granted Dec 3, 1996·85 cites·41 claims
- 0990US8481687B2Anti-ErbB3 antibodiesVINCENT SYLVIE·Filed 2011·Granted Jul 9, 2013·23 cites·12 claims
- 1089US10745476B2Anti-NOTCH3 antibodiesAVEO PHARMACEUTICALS INC·Filed 2018·Granted Aug 18, 2020·5 cites·28 claims
- 1189US7935502B2Hepatocyte growth factor (HGF) binding proteinsAVEO PHARMACEUTICALS INC·Filed 2009·Granted May 3, 2011·7 cites·12 claims
- 1289US6521602B1Anti-neoplastic compositions and uses thereofGPC BIOTECH INC·Filed 2000·Granted Feb 18, 2003·22 cites·11 claims
- 1389US5691147ACDK4 binding assayMITOTIX INC·Filed 1994·Granted Nov 25, 1997·56 cites·1 claims
- 1486US12486332B2Anti-ERBB3 antibodiesAVEO PHARMACEUTICALS INC·Filed 2023·Granted Dec 2, 2025·0 cites·15 claims
- 1586US12258391B2Anti-GDF-15 antibodiesAVEO PHARMACEUTICALS INC·Filed 2023·Granted Mar 25, 2025·0 cites·18 claims
- 1686US10597444B2Anti-GDF15 antibodiesAVEO PHARMACEUTICALS INC·Filed 2017·Granted Mar 24, 2020·4 cites·9 claims
- 1786US10494441B2Anti-ERBB3 antibodiesAVEO PHARMACEUTICALS INC·Filed 2017·Granted Dec 3, 2019·4 cites·7 claims
- 1886US7943344B2Hepatocyte growth factor (HGF) binding proteinsAVEO PHARMACEUTICALS INC·Filed 2009·Granted May 17, 2011·6 cites·11 claims
- 1985US9228021B2Anti-ErbB3 antibodiesAVEO PHARMACEUTICALS INC·Filed 2013·Granted Jan 5, 2016·6 cites·39 claims
- 2084US8481688B2Anti-FGFR2 antibodiesWENG ZHIGANG·Filed 2011·Granted Jul 9, 2013·9 cites·7 claims
- 2182US8268315B2Hepatocyte growth factor (HGF) binding proteinsHAN MAY·Filed 2011·Granted Sep 18, 2012·3 cites·9 claims
- 2281US8603478B2Anti-RON antibodiesWHALEN KERRY·Filed 2011·Granted Dec 10, 2013·6 cites·14 claims
- 2381US5672508AInhibitors of cell-cycle progression, and uses related theretoMITOTIX INC·Filed 1996·Granted Sep 30, 1997·53 cites·37 claims
- 2480US9598498B2Anti-ErbB3 antibodiesAVEO PHARMACEUTICALS INC·Filed 2016·Granted Mar 21, 2017·2 cites·24 claims
- 2577US8273355B2Hepatocyte growth factor (HGF) binding proteinsWINSTON JR WILLIAM M·Filed 2011·Granted Sep 25, 2012·3 cites·9 claims
- 2677US6015692ACDC37 cell-cycle regulatory protein and uses related theretoMITOTIX INC·Filed 1997·Granted Jan 18, 2000·28 cites·26 claims
- 2776US9828635B2Predicting tumor response to anti-ERBB3 antibodiesAVEO PHARMACEUTICALS INC·Filed 2012·Granted Nov 28, 2017·4 cites·8 claims
- 2876US2025277019A1Anti-gdf-15 antibodiesAVEO PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 2974US8575318B2Hepatocyte growth factor (HGF) binding proteinsHAN MAY·Filed 2012·Granted Nov 5, 2013·1 cites·6 claims
- 3074US2023295285A1Methods of reversing cachexia and prolonging survival comprising administering a gdf15 modulator and an anti-cancer agentAVEO PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3173US11680108B2Anti-ErbB3 antibodiesAVEO PHARMACEUTICALS INC·Filed 2019·Granted Jun 20, 2023·0 cites·16 claims
- 3273US9096664B2Nucleic acid encoding hepatocyte growth factor (HGF) binding proteinsAVEO PHARMACEUTICALS INC·Filed 2013·Granted Aug 4, 2015·1 cites·23 claims
- 3373US2025289884A1Anti-notch3 antibodiesAVEO PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 3472US2022403015A1Treatment of congestive heart failure and other cardiac dysfunction using a gdf15 modulatorAVEO PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3570US8580930B2Hepatocyte growth factor (HGF) binding proteinsWINSTON JR WILLIAM M·Filed 2012·Granted Nov 12, 2013·1 cites·9 claims
- 3670US6342356B1Methods and regents for identifying synthetic genetic elementsGPC BIOTECH INC·Filed 2000·Granted Jan 29, 2002·1 cites·36 claims
- 3769US12269877B2Anti-notch3 antibodiesAVEO PHARMACEUTICALS INC·Filed 2020·Granted Apr 8, 2025·0 cites·18 claims
- 3867US6420345B1Methods and reagents for inhibiting angiogenesisCELL GENESYS INC·Filed 1999·Granted Jul 16, 2002·24 cites·21 claims
- 3966US2019292253A1Methods of reversing cachexia and prolonging survival comprising administering a gdf15 modulator and an anti-cancer agentAVEO PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 4064US6420110B1Methods and reagents for isolating biologically active peptidesGPC BIOTECH INC·Filed 1998·Granted Jul 16, 2002·20 cites·42 claims
- 4164US2014178934A1Hepatocyte growth factor (hgf) binding proteinsAVEO PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 4261US2025170079A1Combinations of stat-inhibitors and immune checkpoint inhibitors for the treatment and/or management of cancerTVARDI THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4359US8829164B2Anti-ron antibodiesAVEO PHARMACEUTICALS INC·Filed 2013·Granted Sep 9, 2014·0 cites·11 claims
- 4459US2025084155A1Anti-hsp70 antibodies and therapeutic uses thereofUNIV TEXAS·Filed 2022·Application pending·0 cites
- 4558US11897948B2Treatment of chronic kidney disease and other renal dysfunction using a GDF15 modulatorAVEO PHARMACEUTICALS INC·Filed 2018·Granted Feb 13, 2024·0 cites·27 claims
- 4657US2019292251A1Treatment of congestive heart failure and other cardiac dysfunction using a gdf15 modulatorAVEO PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 4753US2017306008A1Methods of reversing cachexia and prolonging survival comprising administering a gdf15 modulator and an anti-cancer agentAVEO PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 4853US2003157477A1Methods and reagents for identifying synthetic genetic elementsFiled 2001·Application pending·0 cites
- 4953US2013288305A1Anti-fgfr2 antibodiesAVEO PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 5052US6495526B2Inhibitors of cell-cycle progression and uses related theretoGPC BIOTECH INC·Filed 1997·Granted Dec 17, 2002·10 cites·42 claims
Showing the top 50 of 66 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Jeno Gyuris files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →